Horst Olschewski
#133,862
Most Influential Person Now
Researcher
Horst Olschewski's AcademicInfluence.com Rankings
Horst Olschewskicomputer-science Degrees
Computer Science
#6041
World Rank
#6370
Historical Rank
Machine Learning
#1826
World Rank
#1850
Historical Rank
Artificial Intelligence
#2077
World Rank
#2112
Historical Rank
Database
#3162
World Rank
#3296
Historical Rank
Download Badge
Computer Science
Horst Olschewski's Degrees
- Bachelors Computer Science University of Hamburg
Similar Degrees You Can Earn
Why Is Horst Olschewski Influential?
(Suggest an Edit or Addition)Horst Olschewski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Updated clinical classification of pulmonary hypertension. (2009) (3396)
- Inhaled iloprost for severe pulmonary hypertension. (2002) (1369)
- Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. (2004) (1056)
- Diagnosis and differential assessment of pulmonary arterial hypertension. (2004) (999)
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 (2008) (915)
- Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review (2009) (861)
- [Updated clinical classification of pulmonary hypertension]. (2014) (854)
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial (2002) (765)
- Diagnosis and assessment of pulmonary arterial hypertension. (2009) (693)
- [Pulmonary hypertension]. (2012) (672)
- Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension (2006) (639)
- Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. (2000) (627)
- Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension (2002) (516)
- Ambrisentan therapy for pulmonary arterial hypertension. (2005) (491)
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. (2010) (488)
- Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. (2009) (417)
- Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension (1996) (397)
- Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. (1999) (386)
- Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. (2003) (368)
- Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. (2010) (358)
- Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia (2003) (354)
- Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension (2006) (344)
- Pulmonary hypertension in chronic lung disease and hypoxia (2019) (339)
- Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. (2004) (332)
- Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. (1996) (323)
- A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. (2000) (312)
- Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy (2000) (305)
- Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp (2004) (300)
- Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. (2003) (289)
- Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial (2000) (275)
- Prostacyclin therapies for the treatment of pulmonary arterial hypertension (2008) (253)
- Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene (2000) (251)
- Whole-genome sequencing of patients with rare diseases in a national health system (2020) (239)
- Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (238)
- Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. (2009) (236)
- Prostanoid therapy for pulmonary arterial hypertension. (2004) (229)
- Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells (2006) (219)
- Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia (2009) (217)
- Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure (2008) (212)
- Sildenafil treatment for portopulmonary hypertension (2006) (187)
- Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension (2013) (186)
- An official European Respiratory Society statement: pulmonary haemodynamics during exercise (2017) (180)
- [Guidelines on diagnosis and treatment of pulmonary arterial hypertension]. (2005) (178)
- Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension (2007) (175)
- Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities. (2006) (175)
- Pulmonary vascular resistances during exercise in normal subjects: a systematic review (2011) (170)
- Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. (2009) (169)
- Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension (2011) (161)
- Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. (2002) (158)
- Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension–Targeted Therapy: The EURO-MR Study (2014) (150)
- Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. (2014) (150)
- Thermoregulatory, cardiovascular, and muscular factors related to exercise after precooling. (1988) (149)
- PCK2 activation mediates an adaptive response to glucose depletion in lung cancer (2014) (148)
- Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. (2006) (147)
- Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine. (1998) (134)
- Peripheral airway obstruction in primary pulmonary hypertension (2002) (127)
- Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. (2003) (126)
- Prostacyclin and its analogues in the treatment of pulmonary hypertension. (2004) (124)
- Correction: Updated clinical classification of pulmonary hypertension (Journal of the American College of Cardiology (2013) 62, (D34-D41)) (2014) (122)
- Body temperature related factors diminishing the drive to exercise. (1987) (121)
- Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. (2001) (117)
- Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. (2015) (116)
- Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality (2017) (115)
- Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway? (2019) (114)
- Zero reference level for right heart catheterisation (2013) (107)
- Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. (2006) (107)
- Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. (2016) (98)
- ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension (2019) (97)
- Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension. (2013) (96)
- Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. (2011) (96)
- Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries (2012) (96)
- Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. (2010) (92)
- Whole genome sequencing of a sporadic primary immunodeficiency cohort (2018) (92)
- Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. (2014) (91)
- Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage‐gated potassium currents (2005) (90)
- Biomarkers in pulmonary hypertension: what do we know? (2013) (87)
- Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients (2014) (87)
- Quantification of Tortuosity and Fractal Dimension of the Lung Vessels in Pulmonary Hypertension Patients (2014) (86)
- Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype? (2018) (86)
- Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis (2019) (81)
- Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. (2010) (80)
- Nocturnal periodic breathing in primary pulmonary hypertension (2002) (80)
- Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. (2012) (79)
- Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension (2004) (76)
- Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI) (2019) (75)
- The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension (2018) (72)
- Inhaled iloprost is a potent acute pulmonary vasodilator in HIV‐related severe pulmonary hypertension (2004) (71)
- Cellular pathophysiology and therapy of pulmonary hypertension. (2001) (70)
- Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. (2020) (68)
- Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension. (2008) (68)
- Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients. (2015) (68)
- Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations (2011) (67)
- Evaluation of Elevated Mean Pulmonary Arterial Pressure Based on Magnetic Resonance 4D Velocity Mapping: Comparison of Visualization Techniques (2013) (66)
- Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells. (2009) (64)
- Characterization of patients with borderline pulmonary arterial pressure. (2014) (62)
- Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation. (2001) (61)
- A novel channelopathy in pulmonary arterial hypertension. (2013) (59)
- Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension (2002) (59)
- Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients (2011) (58)
- Diagnostik und Therapie der chronischen pulmonalen Hypertonie (2006) (58)
- Physiologic basis for the treatment of pulmonary hypertension. (2001) (57)
- Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization (2015) (57)
- Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension (2014) (56)
- Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. (2011) (55)
- Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. (2020) (55)
- Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension (2006) (54)
- ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Possible impact on the antiarrhythmic action of lidocaine. (1996) (54)
- Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis (2017) (52)
- Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction (2012) (52)
- Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model – role of tumor stroma cells (2014) (51)
- Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis (2018) (48)
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells. (2011) (47)
- Increased neutrophil mediator release in patients with pulmonary hypertension – suppression by inhaled iloprost (2003) (47)
- The Emerging Role of Magnetic Resonance Imaging in the Diagnosis and Management of Pulmonary Hypertension (2008) (45)
- MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas (2017) (43)
- Native myocardial T1 mapping in pulmonary hypertension: correlations with cardiac function and hemodynamics (2016) (43)
- Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease. (2019) (42)
- Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension (2019) (40)
- Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. (2009) (40)
- Between inflammation and thrombosis: endothelial cells in COVID-19 (2021) (40)
- C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study (2020) (39)
- Inhaled iloprost for the treatment of pulmonary hypertension (2009) (39)
- TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers (2016) (39)
- Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung (2001) (38)
- Advantage of buffered solutions or automated capnometry in air-filled balloons for use in gastric tonometry (1997) (38)
- Effect of bupivacaine on ATP-dependent potassium channels in rat cardiomyocytes. (1999) (37)
- Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension (2006) (36)
- Proof-Of-Concept Study To Investigate The Efficacy, Hemodynamics And Tolerability Of Terguride Vs. Placebo In Subjects With Pulmonary Arterial Hypertension: Results Of A Double Blind, Randomised, Prospective Phase IIa Study (2012) (36)
- Investigation of N2H4 and H2O2 decomposition in low and high pressure shock waves (1969) (36)
- Long non‐coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1‐AS1 (2019) (36)
- Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer (2020) (36)
- ARIES-1: A PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF AMBRISENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2006) (36)
- MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. (2019) (36)
- The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells (2018) (35)
- Noninvasive detection of early pulmonary vascular dysfunction in scleroderma. (2009) (34)
- HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? (2012) (34)
- Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation. (2012) (34)
- Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (2004) (33)
- [Pathophysiology of pulmonary hypertension]. (1994) (32)
- Disconnect between Fibrotic Response and Right Ventricular Dysfunction. (2019) (32)
- Network Analysis to Risk Stratify Patients With Exercise Intolerance (2018) (32)
- Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca2+-dependent induction of oxidative stress (2012) (32)
- Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. (2018) (32)
- Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue. (2019) (31)
- Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries (2014) (31)
- Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost (1998) (31)
- Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances. (2021) (30)
- Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31. (2003) (30)
- Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy. (2009) (30)
- Efficient Collisional Energy Transfer of Vibrationally Highly Excited C6F6 Molecules in the Ground Electronic State (1990) (29)
- Resident cell lineages are preserved in pulmonary vascular remodeling (2018) (29)
- Ion channels and transporters as therapeutic targets in the pulmonary circulation. (2014) (29)
- Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. (2020) (29)
- Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography. (2015) (29)
- [Right heart catheterization in pulmonary hypertension]. (2011) (29)
- Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study (2014) (29)
- Effect of sildenafil on hypoxia-induced changes in pulmonary circulation and right ventricular function (2007) (28)
- [Diagnosis and therapy of chronic pulmonary hypertension]. (2007) (28)
- Automated integer programming based separation of arteries and veins from thoracic CT images (2016) (28)
- Delayed Processing of Blood Samples Influences Time to Positivity of Blood Cultures and Results of Gram Stain-Acridine Orange Leukocyte Cytospin Test (2007) (28)
- Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation. (2008) (27)
- Right ventricular fibrosis and dysfunction: Actual concepts and common misconceptions. (2018) (27)
- Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders (2002) (27)
- Importance of kynurenine in pulmonary hypertension. (2017) (26)
- Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes (2007) (26)
- Multi-channel lung sound classification with convolutional recurrent neural networks (2020) (25)
- Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics. (2014) (25)
- Aerosolized vasodilators in pulmonary hypertension. (2002) (25)
- IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis (2019) (25)
- Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) (2020) (25)
- Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach (2018) (25)
- The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension (2017) (24)
- Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40 (2006) (24)
- Inhaled iloprost for severe pulmonary hypertension (2002) (24)
- Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension (2016) (23)
- Pulmonary hypertension in chronic obstructive pulmonary disease (2020) (23)
- Aspergillus oryzae peritonitis in CAPD: case report and review of the literature. (2007) (23)
- Proposed new definition of exercise pulmonary hypertension decreases false-positive cases (2016) (23)
- Enhanced hypoxic pulmonary vasoconstriction in families of adults or children with idiopathic pulmonary arterial hypertension. (2005) (23)
- Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study (2017) (23)
- Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension (2016) (22)
- Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure (2003) (22)
- Severe microcirculatory abnormalities elicited by E. coli hemolysin in the rabbit ileum mucosa. (1999) (22)
- Matwo-CapsNet: A Multi-label Semantic Segmentation Capsules Network (2019) (21)
- Oncogene addiction and tumor mutational burden in non‐small‐cell lung cancer: Clinical significance and limitations (2019) (19)
- Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis (2019) (19)
- Primary pulmonary hypertension is predominantly a hereditary disease. (2002) (19)
- Portopulmonary hypertension: short review. (2010) (19)
- Crackle and Breathing Phase Detection in Lung Sounds with Deep Bidirectional Gated Recurrent Neural Networks (2018) (19)
- Treatment of pulmonary arterial hypertension(PAH) (2010) (19)
- Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension (2018) (19)
- [Recommendations for the choice of inhalatory systems for drug prescription]. (2001) (18)
- CD133+ cells in pulmonary arterial hypertension (2016) (18)
- Intimal sarcoma of the pulmonary valve. (2010) (18)
- Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension (2019) (18)
- TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α. (2017) (18)
- Serotonin transporter gene polymorphism in a cohort of German patients with idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. (2005) (18)
- [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. (2000) (17)
- Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox (2017) (17)
- UV Absorption Study of the Thermal Decomposition Reaction H2S .fwdarw. H2 + S(3P) (1994) (16)
- Quantitative CT‐derived vessel metrics in idiopathic pulmonary fibrosis: A structure–function study (2019) (16)
- ESC-Leitlinie 2015: Diagnostik und Therapie der pulmonalen Hypertonie (2016) (16)
- [Dana Point: what is new in the diagnosis of pulmonary hypertension?]. (2008) (16)
- Basic electrical properties of in situ endothelial cells of small pulmonary arteries during postnatal development. (2001) (15)
- Basement Membrane Remodeling Controls Endothelial Function in Idiopathic Pulmonary Arterial Hypertension (2020) (15)
- Elevated pulmonary vascular resistance predicts mortality in COPD patients (2021) (15)
- Reply: reading of pulmonary artery pressure tracings: the best compromise of accuracy and clinical pertinence. (2014) (15)
- Determination of cardiac output with dynamic contrast-enhanced computed tomography (2013) (14)
- Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells. (2013) (14)
- Reversal of nocturnal periodic breathing in primary pulmonary hypertension after lung transplantation. (2004) (13)
- Sildenafil zur Therapie der schweren pulmonalen Hypertonie und des beginnenden Rechtsherzversagens (2002) (13)
- Pulmonary Lobe Segmentation in CT Images using Alpha-Expansion (2018) (13)
- [Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]. (2010) (13)
- Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition? (2015) (13)
- Dysbalance of ACE2 levels – a possible cause for severe COVID‐19 outcome in COPD (2021) (13)
- Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial Cells (2013) (12)
- TRIUMPH 1: Long-Term Safety and Efficacy of Inhaled Treprostinil Sodium in Patients with Pulmonary Arterial Hypertension (PAH) – Two Year Follow-Up. (2009) (12)
- Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia (2017) (12)
- MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension (2020) (12)
- Pulmonary Histoplasmosis in Three Austrian Travelers After a Journey to Mexico (2008) (12)
- Cardiac responses to the Valsalva manoeuvre in different body positions (2004) (12)
- Prävalenz von Schlaganfall und transitorischer ischämischer Attacke (TIA) bei obstruktiver Schlaf-Apnoe: eine retrospektive Erhebung an 187 konsekutiven Patienten (2000) (11)
- Phospholipid dynamics in ex vivo lung cancer and normal lung explants (2021) (11)
- Gluconeogenesis in cancer: Door wide open (2014) (11)
- Pulmonary Hypertension. (2017) (11)
- PL-7 Positive Antisynthetase Syndrome and Pulmonary Hypertension (2013) (11)
- Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension - Insights From the IBUKI and AIR Studies. (2016) (11)
- Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways (2021) (11)
- Amitriptyline and carbamazepine utilize voltage-gated ion channel suppression to impair excitability of sensory dorsal horn neurons in thin tissue slice: An in vitro study (2016) (11)
- Healthy Lung Vessel Morphology Derived From Thoracic Computed Tomography (2018) (11)
- [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure]. (2002) (10)
- [Therapy of pulmonary arterial hypertension]. (2005) (10)
- Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis. (2020) (10)
- Studies of unimolecular reactions of triatomic molecules (1967) (10)
- Are anticoagulants still indicated in pulmonary arterial hypertension? (2018) (10)
- The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma. (2010) (10)
- Clinical impact of the new definition of pre-capillary pulmonary hypertension. (2021) (10)
- Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review (2022) (10)
- Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6th World Symposium on Pulmonary Hypertension (2019) (10)
- Effect of Inhaled Iloprost during Off-Medication Time in Patients with Pulmonary Arterial Hypertension (2007) (9)
- Physiologie und Pathophysiologie der pulmonalen Zirkulation (1999) (9)
- Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach. (2022) (9)
- Endothelial Dysfunction Following Enhanced TMEM16A Activity in Human Pulmonary Arteries (2020) (9)
- 2567 Long-term survival in patients with pulmonary hypertension inhaling iloprost (2003) (9)
- Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project (2020) (9)
- Mildly increased pulmonary arterial pressure: a new disease entity or just a marker of poor prognosis? (2019) (9)
- No erythropoietin-induced growth is observed in non-small cell lung cancer cells. (2017) (9)
- Measuring health-related quality of life with the Euroqol EQ-5D instrument in clinical trials of new treatments for pulmonary hypertension (2001) (8)
- Imatinib in Patients with Severe Pulmonary Artery Hypertension (PAH) Refractory to Standard Therapy. (2009) (8)
- Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH) (2014) (8)
- Temperature effects on ventilatory rate, heart rate, and preferred pedal rate during cycle ergometry. (1995) (8)
- [Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]. (2016) (8)
- [ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment]. (2016) (8)
- Automatic Artery-Vein Separation from Thoracic CT Images Using Integer Programming (2015) (8)
- The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease (2021) (7)
- Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing? (2019) (7)
- Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension. (2006) (7)
- Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation. (2019) (7)
- Pulmonary arterial pressure in patients with myelodysplastic syndromes (2016) (7)
- [Statement of the Austrian Society of Pneumology (ASP)]. (2020) (7)
- Cologne consensus conference on pulmonary hypertension - Update 2018. (2018) (7)
- The pulmonary haemodynamics during exercise – research network (PEX-NET) ERS Clinical Research Collaboration: investigating the prognostic relevance of exercise haemodynamics (2019) (7)
- [Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]. (2019) (7)
- CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis (2020) (7)
- [Prevalence of stroke and transitory ischemic attacks in obstructive sleep apnea: a retrospective analyis so f 187 consecutive patients]. (2000) (7)
- Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation". (2016) (6)
- Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension. Author's reply (2006) (6)
- [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension]. (1998) (6)
- Pulmonale Hypertonie: Kölner Konsensus-Konferenz 2016 (2016) (6)
- Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension. (2016) (6)
- Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension: a cardiac magnetic resonance imaging case report (2016) (6)
- External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer (2019) (6)
- 838: Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization (2014) (6)
- [ESC guidelines 2015 on pulmonary hypertension]. (2015) (6)
- Long Term Use Of Imatinib In Patients With Severe Pulmonary Arterial Hypertension (2010) (6)
- Detection of pulmonary vasculopathy by novel analysis of oxygen uptake in patients with systemic sclerosis: association with pulmonary arterial pressures. (2014) (6)
- [Current recommendations for the diagnosis and treatment of pulmonary hypertension]. (2006) (6)
- Derzeitige Empfehlungen zur Diagnostik und Therapie der pulmonalen Hypertonie (2006) (5)
- [NO and alternative inhalational therapy approaches in pulmonary hypertension]. (1997) (5)
- Sleep Related Breathing Disorders and Inflammation — The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment (2015) (5)
- Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation (2021) (5)
- Therapie der pulmonalen Hypertonie (2004) (5)
- Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis. (2022) (5)
- Does exercise pulmonary hypertension exist? (2016) (5)
- Novel Role Of SRC Family Tyrosine Kinase (SRCTK) In Response Of Potassium Channels In Human Pulmonary Artery Smooth Muscle Cells To Hypoxia (2011) (4)
- [Supportive therapy in pulmonary arterial hypertension]. (2014) (4)
- Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension (2022) (4)
- Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy (2014) (4)
- TMEM16A Potentiation: Possible Drawbacks (2020) (4)
- A 55-year-old craftsman with dyspnea and clubbing: a case report (2009) (4)
- The definition of pulmonary hypertension: history, practical implications and current controversies (2021) (4)
- Behandlung der Pulmonal Arteriellen Hypertonie (2000) (4)
- Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series (2021) (4)
- Imatinib for right heart failure in COPD (2018) (4)
- NO und alternative inhalative Therapieansätze bei pulmonaler Hypertonie (1997) (4)
- Imatinib for Pulmonary Arterial Hypertension - Wonder Drug or Killer Drug? (2015) (4)
- [Opinion of the Austrian Society of Radiology and the Austrian Society of Pneumology]. (2013) (3)
- Hefemykose in Form multipler Hautinfiltrate durch Trichosporon cutaneum sive beigelii bei Aplastischem Syndrom (1990) (3)
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan (2013) (3)
- [Obstructive sleep apnea and cardiovascular diseases--hypothesis on the pathophysiological interlinks]. (2001) (3)
- [Early diagnosis and therapy in pulmonary hypertension--aspects of a vision]. (2013) (3)
- TRIUMPH: LONG-TERM EFFICACY AND SAFETY OF INHALED TREPROSTINIL SODIUM IN PULMONARY ARTERIAL HYPERTENSION (PAH) (2008) (3)
- Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis (2019) (3)
- [Treatment of pulmonary artery hypertension]. (2000) (3)
- Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease. (2022) (3)
- Neutrophil- to-lymphocyte ratio as a prognostic parameter in pulmonary arterial hypertension (2016) (3)
- Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure (2022) (3)
- A 57-year-old woman with obesity, respiratory insufficiency, and slowed mental state. Diagnosis: Obesity hypoventilation syndrome. (2013) (3)
- Clinical Manifestations of Respiratory Bronchiolitis as an Incidental Finding in Surgical Lung Biopsies: A Retrospective Analysis of a Large Austrian Registry (2015) (3)
- [Imatinib for pulmonary arterial hypertension]. (2014) (3)
- Pulmonale Hypertonie bei Lungenkrankheiten: Empfehlungen der Kölner Konsensus-Konferenz 2016 (2016) (3)
- [Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]. (2000) (3)
- Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of SSc-ILD. (2022) (3)
- Basement Membrane Remodelling Controls Endothelial Function in IPAH. (2020) (3)
- The Association Between Pulmonary Vascular Resistance and Clinical Outcomes in Patients with Pulmonary Hypertension: A Retrospective Cohort Study (2021) (2)
- Wirksamkeit, Sicherheit und Benutzerfreundlichkeit der Trockenpulver-Inhalation von Aclidiniumbromid bei COPD (2018) (2)
- Pulmonary and cardiac drugs: clinically relevant interactions (2019) (2)
- Stellungnahme der Österreichischen Röntgengesellschaft und der Österreichischen Gesellschaft für Pneumologie (2013) (2)
- Low oxygen levels decrease adaptive immune responses and ameliorate experimental asthma in mice (2021) (2)
- Stellungnahme der Österreichischen Gesellschaft für Pneumologie (ÖGP) (2020) (2)
- Einsatz von Imatinib bei Patienten mit Pulmonal Arterieller Hypertonie (2014) (2)
- Pulmonary capillary recruitment in exercise and pulmonary hypertension (2018) (2)
- Pulmonary Hypertension May Be a Relevant Comorbidity in Patients with Myelodysplastic Syndromes (2011) (2)
- Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis (2019) (2)
- The Role of Erythropoietin and its Receptor in Growth and Survival of non-small cell Lung Cancer cells (2012) (2)
- Therapie der pulmonal arteriellen Hypertonie (PAH) Empfehlungen der Kölner Konsensus-Konferenz 2010 (2010) (2)
- Pulmonalembolie und direkte orale Antikoagulantien (2018) (2)
- Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (2)
- Right ventricular tissue doppler echocardiography in pulmonary hypertension (2018) (2)
- Single-cell transcriptomics reveals skewed cellular communication and phenotypic shift in pulmonary artery remodeling (2022) (2)
- Belastungsuntersuchungen in der Pneumologie (2016) (2)
- Pulmonal (arterielle) Hypertonie (2016) (2)
- Clinical-Pathological Conference Series from the Medical University of Graz (2018) (2)
- Pirfenidone and N-acetylcysteine (NAC) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF): Exploratory Efficacy Results From the PANORAMA Study (2015) (1)
- S40 Phenotypic characterisation of GDF2 mutation carriers in a large cohort of patients with pulmonary arterial hypertension (2018) (1)
- Monocytes and Macrophages Serve as Potent Prostaglandin D2 Sources during Acute, Non-Allergic Pulmonary Inflammation (2021) (1)
- Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and chystic fibrosis. (2022) (1)
- Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH (2021) (1)
- afety and Efficacy of Inhaled Treprostinil as Add-On herapy to Bosentan in Pulmonary Arterial Hypertension (2006) (1)
- Novel causative genes for heritable pulmonary arterial hypertension (2017) (1)
- Regional differences in lung vessel morphology from thoracic CT images (2015) (1)
- Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization (2015) (1)
- Thoracentesis and Chest Tube Management in Critical Care Medicine (2015) (1)
- SCREENING FOR PULMONARY ARTERIAL HYPERTENSION WITH EXERCISE-STRESS-ECHOCARDIOGRAPHY AND CARDIOPULMONARY EXERCISE TESTING (2007) (1)
- Efficient Collisional Energy Transfer of Vibrationally Highly Excited C6F6 Molecules in the Ground Electronic State. (1990) (1)
- Impact of smoking behavior on survival following allogeneic hematopoietic stem cell transplantation - smoking cessation matters. (2021) (1)
- Progression of Lung Cancer: Role of Hypoxia and the Metabolic Tumor Microenvironment (2017) (1)
- PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells. (2021) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Inhaled Iloprost for Treatment of Pulmonary Arterial Hypertension (2002) (1)
- No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity (2020) (1)
- [Appetite depressant drugs and the risk of primary pulmonary hypertension]. (1997) (1)
- IMATINIB MESYLATE TREATMENT FOR SEVERE PULMONARY ARTERIAL HYPERTENSION: A PROPOSED PHASE III 24-WEEK DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL (2009) (1)
- Clinical-Pathological Conference Series from the Medical University of Graz (2020) (1)
- MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension (2020) (1)
- [Physiology and physiopathology of the pulmonary circulation]. (1999) (1)
- PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells (2020) (1)
- [Treatment of pulmonary arterial hypertension: prostacyclin analogs]. (2006) (1)
- Impact of borderline pulmonary arterial pressure on survival (2016) (1)
- Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer (2021) (1)
- Dana Point: What is new in diagnostics of pulmonaryhypertension? (2008) (1)
- [Pulmonary hypertension: the future has begun]. (2006) (1)
- Pulmonary vascular disease and exercise hemodynamics in chronic liver disease. (2022) (1)
- Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (1)
- Pulmonary Vascular Resistances during Exercise. (2009) (1)
- [Chronic obstructive pulmonary disease: the right treatment for the right patient]. (2021) (1)
- Identification of novel rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (1)
- Automated vortical blood flow-based estimation of mean pulmonary arterial pressure from 4D flow MRI. (2022) (1)
- Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial (2020) (1)
- Long Term Open Label Treatment with Inhaled Treprostinil for Pulmonary Arterial Hypertension. (2009) (1)
- Should patients with pulmonary hypertension fly and climb? (2018) (1)
- Medikamentöse Therapie der pulmonalen Hypertonie (2005) (1)
- Neue ESC/ERS-Leitlinien für Lungenembolie (2020) (1)
- Pulmonale Hypertonie: Die Zukunft hat begonnen (2006) (1)
- 43. Jahrestagung der Österreichischen Gesellschaft für Pneumologie. 3. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie (2019) (1)
- Moderne bildgebende Verfahren im Management der pulmonalen Hypertonie (2014) (1)
- Sildenafil bei pulmonaler Hypertonie. Kommentar (2003) (1)
- Therapie der pulmonalarteriellen Hypertonie: Prostazyklin-Analoga (2006) (1)
- ESC-Leitlinien 2015 zur pulmonalen Hypertonie (2015) (1)
- Diagnostik der akuten Lungenembolie (2000) (1)
- Therapie der pulmonal arteriellenHypertonie (PAH) (2010) (1)
- SAT0553 QUANTITATIVE ANALYSIS OF IMAGING FEATURES AT CHEST CT OF PULMONARY ARTERIAL AND VENOUS COMPONENTS IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD). (2020) (1)
- The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines (2015) (0)
- Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension – results from a prospective cross-sectional study (2017) (0)
- Chapter 6.4. Pulmonary Hypertension (2007) (0)
- Acute hemodynamic effects of NO and sildenafil during right heart catheterization in PAH and nonPAH-PH (2015) (0)
- Results of pasture management in the medium altitude mountains of the GDR. (1980) (0)
- High-intensity grassland management in Karl-Marx-Stadt [German D.R.] region, following 1987 grassland credit assessment - Results and challenge (1988) (0)
- Exacerbated Lung Function and Eosinophilic Inflammation After Blockage of Innate Immune Signalling in a Mouse Model of Systemic Sclerosis-Associated Lung Fibrosis (2020) (0)
- A Phase 2, double-blind, placebo-controlled study of N–acetylcysteine in combination with pirfenidone in patients with idiopathic pulmonary fibrosis (2014) (0)
- An intrinsic tryptophan metabolite acts as pulmonary vasodilator in pulmonary hypertension (2017) (0)
- [Pulmonary (Arterial) Hypertension]. (2016) (0)
- Recognition of early pulmonary structural changes with real-time high fidelity expiratory CO2 analysis (2022) (0)
- Magnetic resonance-derived three-dimensional blood flow patterns as marker of manifest pulmonary hypertension (2009) (0)
- Why We Should Care about the Mysteries of Pulmonary Hypertension (2016) (0)
- Covid-19-what we know for sure (2020) (0)
- Potassium Channels in the Transition from Fetal to the Neonatal Pulmonary Circulation (2022) (0)
- Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease (2022) (0)
- Pulmonary hypertension in hypersensitivity pneumonitis. (2016) (0)
- P62.08 Expression Pattern and Prognostic Significance of Gluconeogenesis Enzymes in Lung Cancer. (2021) (0)
- Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance (2013) (0)
- 354: Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer (2014) (0)
- Dehydroepiandrosterone and GDF-15 for follow-up of patients with pulmonary arterial hypertension (2021) (0)
- OnlyCaps-Net, a Capsule only Based Neural Network for 2D and 3D Semantic Segmentation (2022) (0)
- Genetic determinants of risk and survival in pulmonary arterial hypertension (2018) (0)
- Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study (2023) (0)
- Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension (2017) (0)
- Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise (2017) (0)
- Bosentan in the Treatment of Pulmonary Arterial Hypertension in Adults with Congenital Heart Defects: Preliminary Experience of a Multicenter Cooperation Project (2005) (0)
- Impact of the new definition of precapillary pulmonary hypertension on patient disposition (2020) (0)
- Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifα destabilization (2013) (0)
- Acknowledgement to the Reviewers (2002) (0)
- Quantification Of Lung Vessel Tortuosity In Pulmonary Hypertension Patients (2014) (0)
- [Vasotropic therapy and artificial respiration for pulmonary hypertension]. (1999) (0)
- [Imaging techniques for diagnosis and clinical monitoring of pulmonary arterial hypertension]. (2009) (0)
- Discordant perception of global health between COPD outpatients and their physicians – real world data from the CLARA project (2020) (0)
- [Diagnosis of pulmonary hypertension - novelties after the 5th world conference]. (2014) (0)
- Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension (2020) (0)
- Loss of ABCG2 leads to right ventricular diastolic dysfunction in pulmonary hypertension (2013) (0)
- The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension (2012) (0)
- Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension (2014) (0)
- INVESTIGATIONS OF THE THERMAL DECOMPOSITION OF SMALL MOLECULES, ESPECIALLY AT HIGH PRESSURES. (1966) (0)
- Pulmonary Vascular Resistances are Predictors of 3-year-survival in Systemic Sclerosis (2020) (0)
- Contents Vol. 76, 2008 (2008) (0)
- COPD_A_252033 1655..1663 (2020) (0)
- Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature (2011) (0)
- Regulation der Kaliumkanäle in humanen pulmonal-arteriellen glatten Muskelzellen (2011) (0)
- Fully-automatic lung fissure detection from thoracic computed tomography images (2017) (0)
- Pulmonary arterial hypertension: current therapies (2003) (0)
- Determination of cell-derived microparticles in patients with pulmonary hypertension and connective-tissue diseases using flow cytometry (2011) (0)
- [Diagnosis and treatment of pulmonary hypertension]. (2006) (0)
- Age dependent changes in lung arteries and veins in healthy women and men (2016) (0)
- [Modern imaging methods in the management of pulmonary hypertension]. (2014) (0)
- [Vasodilators in right heart failure -- pro]. (2004) (0)
- Complex sleep apnea occuring after intracerebral haemorrhage with treatment by adaptive servoventilation in two patients: a case report (2008) (0)
- Age-related changes in lung vessel morphology in healthy men and women (2017) (0)
- Early Therapy With Bosentan Reverses Progressing Pulmonary Vasculopathy In Scleroderma Patients (2010) (0)
- Right axis deviation is a strong indicator of pulmonary hypertension in a risk population (2011) (0)
- 42. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 2. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie (2018) (0)
- Contents Vol. 89, 2015 (2015) (0)
- Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT (2019) (0)
- 94 Exercise-induced changes of pulmonary arterial pressure in patients with myelodysplastic syndromes (2011) (0)
- Abstract 17865: Right Ventricular Diastolic Dysfunction in ABCG2 knockout mice under Hypoxia (2013) (0)
- Explorer EXPRESS : Statement on imaging and pulmonary hypertension from 1 the Pulmonary Vascular Research Institute ( PVRI ) (2019) (0)
- Lungengefäßerkrankungen (2008) (0)
- Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension (2015) (0)
- Survival in patients with borderline pulmonary arterial pressure (2016) (0)
- Eosinophilic inflammation and worsening of lung function upon pirfenidone treatment in Fra-2 transgenic mice (2018) (0)
- Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension (2014) (0)
- Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo (2021) (0)
- Native T1 times in the ventricular insertion-points detect pulmonary hypertension with high diagnostic accuracy (2015) (0)
- Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD (2022) (0)
- Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy (2013) (0)
- Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in IPF: PANORAMA (2016) (0)
- Blood Flow Vortices along the Main Pulmonary artery Measured with M r imaging for Diagnosis of Pulmonary (2015) (0)
- Reduced Venous Vessel Density in Pre-Capillary Pulmonary Hypertension (2016) (0)
- 952Mean pulmonary arterial pressure estimated from vortical blood flow in the main pulmonary artery: Definition of cut-off criteria for the diagnosis of pulmonary hypertension (2013) (0)
- Clinical relevance of mildly elevated pulmonary arterial pressure submitted (2020) (0)
- Erfolgreiche Behandlung einer schweren interstitiellen Pneumonie durch Entfernung zirkulierender Autoantikörper: eine Fallserie (2021) (0)
- [Research in Austria - the Ludwig Boltzmann Institute for Lung Vascular Research]. (2016) (0)
- Early Diagnosis of Pulmonary Hypertension by Magnetic Resonance Imaging (MRI) (2010) (0)
- The proANP increase during exercise may predict the PAP increase in connective tissue disease patients at risk of PAH (2012) (0)
- Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study (2014) (0)
- Exercise hemodynamics in patients with COPD (2020) (0)
- Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis (2014) (0)
- P501 CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH PORTAL HYPERTENSION AND EARLY STAGE LIVER DISEASE (2014) (0)
- Diagnostik und Therapie der chronischen pulmonalen Hypertonie Diagnosis and Therapy of Chronic Pulmonary Hypertension (2006) (0)
- Reply to: Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy. (2023) (0)
- Prostacyclin and Prostaglandins (2011) (0)
- Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry (2022) (0)
- [The place of lysis in acute pulmonary embolism]. (2006) (0)
- Impaired exercise capacity in early stage liver cirrhosis - a prospective cross-sectional study (2014) (0)
- Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (0)
- Effect of inhaled lloprost during off-medication time in patients with pulmonary arterial hypertension. Commentary (2007) (0)
- [Introduction to the topic]. (2020) (0)
- Comprehensive Profiling of Endothelial Cell Surface and Adhesion Molecules in Pulmonary Fibrosis (2022) (0)
- Beyond Warburg effect: Adaptation to low glucose involves use of glutamine as alternative carbon source in lung cancer cells (2015) (0)
- [Pulmonary hypertension]. (2002) (0)
- The role of gas exchange measurements during exercise in the detection of early pulmonary arterial hypertension in scleroderma patients - a multi-center analysis (2013) (0)
- Left atrial acceleration factor as a magnetic resonance 4D flow measure of mean pulmonary artery wedge pressure in pulmonary hypertension (2022) (0)
- LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion (2016) (0)
- Pulmonal (arterielle) Hypertonie Pulmonary (Arterial) Hypertension (2016) (0)
- avorable Effects of Inhaled reprostinil in Severe Pulmonary Hypertension (2006) (0)
- Herausforderungen bei der Diagnostik der pulmonalen Hypertonie (2015) (0)
- 235 COMPLEX SLEEP APNEA UNDER ASV AND ASSOCIATED CLINICAL RISK FACTORS (2009) (0)
- Lung vessel morphology changes with airway obstruction (2020) (0)
- Non-invasive measurement of elevated mean pulmonary arterial pressure (2009) (0)
- The role of ABCG2 transporter in Pulmonary Hypertension (PH) (2017) (0)
- Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study (2019) (0)
- Basement membrane, a specialized extracellular matrix, shapes endothelial function in IPAH (2020) (0)
- Normalized Vessel Volume from Quantitative Computed Tomography Predicts Survival in Idiopathic Pulmonary Fibrosis (2019) (0)
- Oral Sildenafil as Long-Term Adjunct Therapy to Inhaled Iloprost in Severe Pulmonary Arterial Hypertension (2016) (0)
- [Pulmonary hypertension--diagnostic and current concepts]. (2014) (0)
- Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different? (2016) (0)
- Advancing into the details of pulmonary haemodynamics during exercise (2018) (0)
- 236 EFFECT OF BILEVEL VENTILATION ON RESPIRATORY CAPACITY IN VARIOUS DISEASES (2009) (0)
- The role of ABCG2 transporter in Pulmonary Hypertension (PH) (2017) (0)
- The Effect of Nintedanib on Pulmonary Vascular Tone in an Experimental Model of Lung Fibrosis and Pulmonary Hypertension (2019) (0)
- RESEARCH ARTICLE Biomarkers in Lung Diseases: From Pathogenesis to Prediction to New Therapies Importance of kynurenine in pulmonary hypertension (2017) (0)
- THU0340 IMPACT OF LANIFIBRANOR, A PAN-PPAR AGONIST, ON THE PULMONARY VASCULAR TONE (2019) (0)
- Increased right atrial pressure is associated with elevated PLMS and sleep disordered breathing in patients with pulmonary hypertension (2011) (0)
- AMLP-Conv, a 3D Axial Long-range Interaction Multilayer Perceptron for CNNs (2022) (0)
- Hypoxia Pulmonary Arterial Hypertension : Results of a Multicenter European Analysis of Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial (2009) (0)
- Impact of cardiopulmonary comorbidities on pulmonary hemodynamics (2015) (0)
- The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis (2020) (0)
- Exercise Pulmonary Vascular Resistances are Predictors of Survival in Systemic Sclerosis (2020) (0)
- Impairment of Inspiratory Muscle Function after COVID-19 (2022) (0)
- 576 Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer (2010) (0)
- Fractal dimension of lung vessels negatively correlates with hemodynamics of patients (2013) (0)
- * HypertensionDevices, in Severe Pulmonary Inhaled Iloprost, Aerosolized by Three Pharmacodynamics and Pharmacokinetics of (2003) (0)
- Erratum: (Journal of Medical Genetics (2003) 40 (865-871)) (2004) (0)
- 192 Constitutive expression of carbonic anhydrase IX in hypoxic and normoxic non-small cell lung cancer fragments (2010) (0)
- [Highlights in pulmonary hypertension]. (2007) (0)
- Circulating microRNAs as molecular biomarkers for lung adenocarcinoma. (2022) (0)
- No indication of insulin resistance in idiopathic PAH with preserved physical activity (2020) (0)
- IP-10 and IL-6 as biomarkers in Chronic Thromboembolic Pulmonary Hypertension (2013) (0)
- 538 Autocrine vascular endothelial growth factor signaling has no influence on the apoptosis induction by cisplatin in non-small cell lung cancer cell lines (2010) (0)
- Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model – role of tumor stroma cells (2014) (0)
- Early therapy with bosentan may reverse pulmonary vasculopathy in scleroderma patients (2010) (0)
- LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMA (2015) (0)
- D-Dimer predicts mortality in a real-life cohort of patients with indication for right heart catheterization (2022) (0)
- Severe Pulmonary Hypertension in COPD (2022) (0)
- Magnetresonanz-basierte Messung des erhöhten, mittleren pulmonalarteriellen Drucks (2009) (0)
- Beeinträchtigung der inspiratorischen Muskelfunktion nach COVID-19 (2023) (0)
- Bestimmung und prognostische Relevanz der rechtsventrikulären kontraktilen Reserve bei Patienten mit pulmonal arterieller Hypertonie (2013) (0)
- Update pulmonale Hypertonie mit Fokus auf Lungenkrankheiten (2021) (0)
- Forschung in Österreich – das Ludwig Boltzmann Institut für Lungengefäßforschung (2016) (0)
- 45. Jahrestagung der Österreichischen Gesellschaft für Pneumologie5. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie (2021) (0)
- Pulmonale Hypertonie und rheumatische Erkrankungen (2018) (0)
- [Cerebral calcification in idiopathic hypoparathyroidism]. (1988) (0)
- Masterplan 2025 der Österreichischen Gesellschaft für Pneumologie (ÖGP) – die erwartete Entwicklung und Versorgung respiratorischer Erkrankungen in Österreich (2020) (0)
- Prognostic relevance of differential blood count in pulmonary arterial hypertension (2016) (0)
- Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie (2010) (0)
- Jahrestagung 2009 der Österreichischen Gesellschaft für Pneumologie, Salzburg, 11. Bis13. Juni 2009 (2009) (0)
- 36. Jahrestagung der Deutschen Gesellschaft für Pädiatrische Kardiologie (2004) (0)
- Licht und Luft (2021) (0)
- Niedrig dosierte Atem- und Bewegungstherapie verbessert die körperliche Leistungsfähigkeit und die Lebensqualität bei Patienten mit schwerer chronischer pulmonaler Hypertonie (2006) (0)
- Prognostic Impact of Pulmonary Hemodynamics at Submaximal Exercise- Results from a Single-Center Database (2020) (0)
- Frühdiagnostik der pulmonalen Hypertonie mittels Magnet-Resonanz-Tomografie (MRT) (2010) (0)
- Take your drug and climb Machu Picchu! (2019) (0)
- Validation of cardiac MR parameters in the assessment of pulmonary hemodynamics (2017) (0)
- These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details (2014) (0)
- 113P C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study (2020) (0)
- The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma (2012) (0)
- Schlüssel zur Diagnostik in der Pneumologie (2020) (0)
- MR-basierte Bestimmung des pulmonalarteriellen Mitteldrucks und Diagnose von Pulmonalhypertonie (2013) (0)
- Jahrestagung 2007 der Österreichischen Gesellschaft für Pneumologie. Salzburg, 4.–6. Oktober 2007 (2007) (0)
- Inhalative Therapie mit Iloprost verursacht nachts kein Rebound bei Patienten mit schwerer idiopathischer pulmonaler Hypertonie (2006) (0)
- Updated definition of exercise pulmonary hypertension (2022) (0)
- Was ist pulmonale Hypertonie? – Eine Definition anhand der aktuellen Leitlinien (2014) (0)
- Administration de treprostinil utilisant un inhalateur a dose mesuree (2007) (0)
- Was definiert eine frühe pulmonal-arterielle Hypertonie? (2011) (0)
- Langzeitergebnisse eines Screenings auf pulmonale Hypertonie nach Lungenembolie (2014) (0)
- Single Cell Transcriptomics Unveils Smooth Muscle Cell Heterogeneity in Pulmonary Artery Compartment (2020) (0)
- COPD – eine entzündliche Erkrankung (2015) (0)
- Kovacs: Zero reference level (2013) (0)
- Medikamentöse Therapie der pulmonal arteriellen Hypertonie (2015) (0)
- HbA1c bei pulmonalarterieller Hypertonie – ein Marker mit prognostischer Relevanz? (2010) (0)
- Lungen- und Atemwegserkrankungen (2009) (0)
- Aktuelle Fragestellungen und neue Möglichkeiten im Bereich der PAH (2010) (0)
- Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten (2021) (0)
- Kurzatmiger Patient — nicht immer ist er nur untrainiert (2014) (0)
- 25 Jahre Reanimation mit Amiodaron in Deutschland (2022) (0)
- Impact of diastolic dysfunction on exercise capacity in patients with liver cirrhosis (2018) (0)
- Inhalative Strategien zur Verbesserung der pulmonalen Hämodynamik und des Gasaustausches bei Sepsis und schwerer pulmonaler Hypertonie (2000) (0)
- Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6 th World Symposium on Pulmonary Hypertension Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6 th World Symposium on Pulmonary Hypertension (2019) (0)
- Nichtinvasive Detektion einer abnormalen pulmonalen Druckreaktion auf Stress bei Angehörigen von Patienten mit Idiopathischer pulmonal-arterieller Hypertonie (2007) (0)
- Risikofaktoren für Lungenkrankheiten (2018) (0)
- Endotyping COPD: hypoxia-inducible factor-2 as a molecular “switch” between the vascular and airway phenotypes? (2023) (0)
- mbrisentan Therapy for ulmonary Arterial Hypertension (0)
- Covid‑19 – was wir sicher wissen (2020) (0)
- Nichtinvasive Bestimmung des pulmonalarteriellen Verschlussdrucks bei Patienten mit Pulmonalhypertonie mittels 4D MR-Phasenkontrastbildgebung (2013) (0)
- [Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria]. (2020) (0)
- Whole-genome sequencing of patients with rare diseases in a national health system (2020) (0)
- Phospholipid dynamics in ex vivo lung cancer and normal lung explants (2021) (0)
- Schwere pulmonale Hypertonie - Vasodilative Therapie in der Lungenstrombahn (2000) (0)
- Increased Tortuosity of Pulmonary Arteries in Patients with Pulmonary Hypertension in the Arteries (2015) (0)
- Pulmonary exercise hemodynamics in patients with liver cirrhosis – a stress echocardiography study (2020) (0)
- Nicht-invasive Evaluation der pulmonalen Zirkulation bei Angehörigen von Patienten mit idiopathischer pulmonalarterieller Hypertonie (2013) (0)
- Vasotrope Therapie und Beatmung bei pulmonaler Hypertonie (1999) (0)
- Pulmonale Hypertonie bei Lungenerkrankungen – zielgerichtete Therapie? (2017) (0)
- PGE1 UND PGI2 IN DER THERAPIE DER PULMONALEN HYPERTONIE : UBERSICHT UND PERSPEKTIVEN (1993) (0)
- Pulmonale veno-okklusive Erkrankung (2016) (0)
- Pulmonaler Hochdruck (2002) (0)
- 20 JAHRE LAERMBEKAEMPFUNG IM BAUBETRIEB - ENTWICKLUNG - TRENDS - TENDENZEN (1984) (0)
- PULMONALE HYPERTONIE : DIAGNOSE, THERAPIE UND PROGNOSE (1993) (0)
- Kölner Konsensus Konferenz zur pulmonalen Hypertonie 2016 (2016) (0)
- RGS5 Determines Neutrophil Migration in the Acute Inflammatory Phase of Bleomycin-Induced Lung Injury (2021) (0)
- Pulmonale Zirkulationsveränderungen bei Hypoxie und Höhenaufenthalt und der Einfluss von Sildenafil – Eine Doppler-Echokardiographische Untersuchung (2005) (0)
- Should Patients With Connective Tissue Disease Undergo Exercise Doppler Echocardiography?: Response (2010) (0)
- Screening auf pulmonale Hypertonie (2017) (0)
- Diagnostik und Therapie der chronischen pulmonalen Hypertonie Diagnosis and Therapy of Chronic Pulmonary Hypertension (2006) (0)
- Compartment-specific Remodeling of End-stage Chronic Obstructive Pulmonary Disease Patients With Severe Pulmonary Hypertension Based on Histological Lung Tissue Samples (2023) (0)
- Pulmonary Vascular Remodeling May Precede Pulmonary Arterial Pressure Elevation in Pulmonary Veno-occlusive Disease- A Report of Three Cases (2023) (0)
- D-Dimer Predicts Mortality in Patients with Suspected Pulmonary Hypertension (2020) (0)
- Hemodynamic and clinical relevance of "borderline pulmonary hypertension" (2013) (0)
- Exercise Pulmonary Hypertension (2012) (0)
- Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) (2022) (0)
- 950Estimation of pulmonary arterial mean and wedge pressure by 4-dimensional magnetic resonance blood flow imaging in patients with pulmonary hypertension (2013) (0)
- Bronchiolitis Obliterans In Allogeneic Haematopoietic Stem Cell Transplantation Following Nonmyeloablative Conditioning (2010) (0)
- [Diagnosis of acute pulmonary embolism. Recommendations of the German Society of Pneumology]. (2000) (0)
- Pharmacological management of pulmonary circulation in critically ill patients (2011) (0)
- Understanding exercise hemodynamics (2017) (0)
- [Diagnosis and therapy of chronic pulmonary hypertension]. (2006) (0)
- End-stage COPD patients with severe pulmonary hypertension have less airspace enlargement in histologic samples of explanted lungs (2022) (0)
- [Drug therapy of primary and secondary pulmonary hypertension]. (2002) (0)
- Fluorescence activated cell sorting for simultaneous assessment of nine surface markers of circulating endothelial progenitor cells in pulmonary hypertension (2012) (0)
- Subject Index Vol. 76, 2008 (2008) (0)
- [Targeted therapy of pulmonary arterial hypertension (PAH)]. (2014) (0)
- The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension (2012) (0)
- Synergistic Effects of Nintedanib and Sildenafil on the Pulmonary Vasculature (2020) (0)
- Comparison Of Quantitative Lung Vessel Tortuosity And Echocardiography For Non-Invasive Detection Of Pulmonary Hypertension (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Horst Olschewski?
Horst Olschewski is affiliated with the following schools:
